未知生产厂商
AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).
AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).
AVI-4020 has rapid response therapeutics that plays a significant role in the future of antiviral therapeutics, especially in combating emerging infectious diseases that threaten public health or in combating bioterrorism.
Investigated for use/treatment in infectious and parasitic disease (unspecified) and viral infection.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
